E-LIB Suche - Ergebnisse für: Rini, Joel

1

Genetic pleiotropy and the shared pathological features of ..:

Rini, James ; Asken, Breton ; Geier, Ethan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137543/. , 2021

Link: http://www.ncbi.nlm.nih...

2

Genetic pleiotropy and the shared pathological features of ..:

Rini, James ; Asken, Breton ; Geier, Ethan...
qt2m7413b6. , 2021

Link: https://escholarship.org..

3

Feasibility and Acceptability of a Multidisciplinary Academ..:

Rini, James Fraser ; Tsoy, Elena ; Peet, Bradley...
qt75f44521. , 2022

Link: https://escholarship.org..

4

Feasibility and Acceptability of a Multidisciplinary Academ..:

Rini, James Fraser ; Tsoy, Elena ; Peet, Bradley...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757120/. , 2022

Link: http://www.ncbi.nlm.nih...

5

Safety and Efficacy of Nivolumab in Patients With Metastati..:

George, Saby ; Motzer, Robert J ; Hammers, Hans J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568541/. , 2016

Link: http://www.ncbi.nlm.nih...

6

Phase III Trial of Bevacizumab Plus Interferon Alfa Versus ..:

Rini, Brian I ; Halabi, Susan ; Rosenberg, Jonathan E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860433. , 2010

Link: http://www.ncbi.nlm.nih...

7

Bevacizumab Plus Interferon Alfa Compared With Interferon A..:

Rini, Brian I ; Halabi, Susan ; Rosenberg, Jonathan E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2651074. , 2008

Link: http://www.ncbi.nlm.nih...

8

Genetic pleiotropy and the shared pathological features of ..:

James Rini (10352299) ; Breton Asken (10352302) ; Ethan Geier (1997362)...
https://figshare.com/articles/journal_contribution/Genetic_pleiotropy_and_the_shared_pathological_features_of_corticobasal_degeneration_and_progressive_supranuclear_palsy_a_case_report_and_a_review_of_the_literature/14268520. , 2021

Link: https://doi.org/10.6084/..

9

Quantifying primaquine effectiveness and improving adherenc..:

Kamala Thriemer ; Albino Bobogare ; Benedikt Ley...
http://link.springer.com/article/10.1186/s12936-018-2380-8. , 2018

Link: https://doi.org/10.1186/..

10

Piperaquine pharmacokinetics during intermittent preventive..:

Chotsiri, Palang ; Gutman, Julie ; Ahmed, Rukhsana...
https://archive.lstmed.ac.uk/16585/2/STOPMIP_PopPK_MS_R2.0_clean_version.docx. , 2021

Link: https://archive.lstmed.a..

11

Piperaquine Pharmacokinetics during Intermittent Preventive..:

Chotsiri, Palang ; Gutman, Julie R ; Ahmed, Rukhsana...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092554/. , 2021

Link: http://www.ncbi.nlm.nih...

12

Quantifying primaquine effectiveness and improving adherenc..:

Thriemer, Kamala ; Bobogare, Albino ; Ley, Benedikt...
https://archive.lstmed.ac.uk/8852/1/malaria%20journal__meeting%20report_APMEN%20Vivax%20working%20group.pdf. , 2018

Link: https://archive.lstmed.a..

13

Quantifying primaquine effectiveness and improving adherenc..:

Thriemer, Kamala ; Bobogare, Albino ; Ley, Benedikt...
https://researchonline.lshtm.ac.uk/id/eprint/4648301/1/Quantifying%20primaquine%20effectiveness%20and%20improving%20adherence_GOLD%20VoR.pdf. , 2018

Link: https://researchonline.l..